B. Metzler seel. Sohn & Co’s Charles River Laboratories CRL Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,290	Closed	-$3.05M	–	725
2025 Q4	$3.05M	Buy	+15,290	New	+$2.77M	0.03%	298
2025 Q1	–	Sell	-2,542	Closed	-$469K	–	747
2024 Q4	$469K	Buy	2,542 +1,416	+126%	+$273K	﹤0.01%	652
2024 Q3	$222K	Hold	1,126	–	–	﹤0.01%	742
2024 Q2	$233K	Buy	1,126 +69	+7%	+$15.6K	﹤0.01%	737
2024 Q1	$286K	Hold	1,057	–	–	﹤0.01%	702
2023 Q4	$250K	Hold	1,057	–	–	﹤0.01%	713
2023 Q3	$207K	Hold	1,057	–	–	﹤0.01%	703
2023 Q2	$222K	Hold	1,057	–	–	﹤0.01%	698
2023 Q1	$213K	Hold	1,057	–	–	﹤0.01%	700
2022 Q4	$230K	Buy	+1,057	New	+$231K	﹤0.01%	676
2022 Q2	–	Sell	-789	Closed	-$224K	–	730
2022 Q1	$224K	Hold	789	–	–	﹤0.01%	741
2021 Q4	$297K	Sell	789 -1,400	-64%	-$544K	﹤0.01%	643
2021 Q3	$903K	Buy	2,189 +1,400	+177%	+$581K	0.01%	456
2021 Q2	$292K	Buy	+789	New	+$263K	﹤0.01%	627

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

B. Metzler seel. Sohn & Co's CRL Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 15,290 shares — an estimated $3.05M sold.

B. Metzler seel. Sohn & Co first reported a position in CRL in Q2 2021 and held it in 14 quarters. The position peaked at $3.05M in Q4 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

B. Metzler seel. Sohn & Co reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
B. Metzler seel. Sohn & Co sold 15,290 Charles River Laboratories shares in Q1 2026, an estimated $3.05M.
B. Metzler seel. Sohn & Co first reported a position in Charles River Laboratories in Q2 2021 and held it in 14 quarters.
B. Metzler seel. Sohn & Co's Charles River Laboratories position peaked at $3.05M in Q4 2025.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.